Polyphor Ltd and Axxam SpA Announce Ion Channel Collaboration
News Apr 13, 2010
Polyphor Ltd and Axxam SpA have announced a joint discovery agreement with a synergistic combination of their discovery platforms.
Under the terms of the collaboration the two companies will work together to discover and develop innovative drug candidates for selected therapeutic areas such as pain, inflammation, and metabolic disorders.
Axxam will apply its expertise and outstanding Hit Discovery platforms and capabilities, and Polyphor will provide its unique, proprietary PEM finder® library for screening together with its expertise in medicinal chemistry, drug discovery and development. The collaboration comprises several discovery programs addressing attractive ion channel based targets.
Concept Life Sciences appoints New Group Programme Manager and US Head of SalesNews
Key leadership appointments support integration of the Group and expansion in the US market.READ MORE